Frazier Life Sciences Management, L.P.

Q4 2022 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Steve R. Bailey - Chief Financial Officer and Chief Compliance Officer
Location
Palo Alto, CA
Holdings as of
December 31, 2022
Value $
$1.61B
Num holdings
44
Date filed
2/7/2023, 02:30 PM
Form type
13F-HR/A-1 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included HLVX, IMGO, ARQT, KDNY, and NAMS.
Previous filing
Q3 2022 - Nov 14, 2022
Next filing
Q1 2023 - May 15, 2023
SEC
View on sec.gov
Filing 2022 Q4 - Restatement compared to 2022 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Steve R. Bailey Chief Financial Officer and Chief Compliance Officer Menlo Park, California 2/7/2023